Table 5.
Recommendations for DVT/PTE prophylaxis.
| Prophylaxis according to DVT/PTE risk calculation | ||
|---|---|---|
| low Risk | Moderate Risk | High Risk |
| Non-Pharmacological Measures: | Pharmacological Measures: | Pharmacological Measures: |
| Active movement of lower limbs | Enoxaparin 20 mg SC 1x/d | Enoxaparin 40 mg SC 1x/d |
| Early walking | Nadroparin 0.3 ml SC 1x/d | Nadroparin 0.6 ml SC 1x/d |
| Medium-compression elastic stockings up to the thighs, or | Dalteparin 2,500 UI SC 1x/d | Dalteparin 5,000 UI SC 1x/d |
| Intermittent pneumatic compression | Heparin 5,000 UI SC 2x/d | Heparin 5,000 UI SC 3x/d |
| Always in association with the non-pharmacological measures | Always in association with the non-pharmacological measures | |